Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (18)

« Back to Publications

Novel and optimized diagnostics for pediatric TB in endemic countries: NOD-pedFEND study protocol.

Song R. et al, (2025), BMC Pediatr, 25

Exhaled breath analysis: A promising triage test for tuberculosis in young children.

Bijker EM. et al, (2024), Tuberculosis (Edinb), 149

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993

Sensitive and Feasible Specimen Collection and Testing Strategies for Diagnosing Tuberculosis in Young Children.

Song R. et al, (2021), JAMA Pediatr, 175

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Voysey M. et al, (2021), Lancet, 397, 881 - 891

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2021), Nat Med, 27, 279 - 288

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ. et al, (2021), Nat Med, 27, 270 - 278

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Voysey M. et al, (2021), Lancet, 397, 99 - 111

Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.

Sudbury EL. et al, (2020), J Infect, 81, 873 - 881

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.

Götzinger F. et al, (2020), Lancet Child Adolesc Health, 4, 653 - 661

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Folegatti PM. et al, (2020), Lancet, 396, 467 - 478

Clinical characteristics and diagnostic test performance among children evaluated for tuberculosis in Kenya

Click E. and SONG R., (2020)

Advanced immunodiagnostic tests for paediatric tuberculosis.

Villanueva P. et al, (2019), Lancet Infect Dis, 19, 467 - 468

Development of colorimetric sensor array for diagnosis of tuberculosis through detection of urinary volatile organic compounds.

Sandlund J. et al, (2018), Diagn Microbiol Infect Dis, 92, 299 - 304

Commercial products to preserve specimens for tuberculosis diagnosis: a systematic review.

Reeve BWP. et al, (2018), Int J Tuberc Lung Dis, 22, 741 - 753

Load More